Gene · 8493
Papers2,396
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,396
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic evolution following cancer treatment in normal tissue. | Nature | 2026 | 41372419 | PubTator, text mining | PubMed |
| Transcriptomics-guided high-throughput drug screening identifies potent therapies for P53 pathway altered DIPG/DMG. | Neuro Oncol | 2026 | 40973093 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis in Nonmalignant Disease: Functional Consequences of Mutated Immune Cells by Clonal Hematopoiesis in the Diseased Tissue. | Annu Rev Pathol | 2026 | 40929507 | PubTator, text mining | PubMed |
| Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease. | Eur Heart J | 2026 | 40900105 | PubTator, text mining | PubMed |
| Clonal hematopoiesis of indeterminate potential and atrial fibrillation. | Heart Rhythm | 2026 | 40368291 | PubTator, text mining | PubMed |
| Case report of two patients with refractory HIV-related B-cell lymphoma treated with the monoclonal antibody glofitamab for secondary central nervous system involvement. | Front Oncol | 2025 | 41783646 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis of Indeterminate Potential and Cardiometabolic Disease: Challenges, Controversies and Future Perspectives. | Int J Mol Sci | 2025 | 41516113 | PubTator, text mining | PubMed |
| Multi-Level Profiling of MAPK-Associated Genes and MicroRNAs Uncovers Regulatory Networks in Breast Cancer Subtypes. | Int J Mol Sci | 2025 | 41465262 | PubTator, text mining | PubMed |
| Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development. | Curr Hematol Malig Rep | 2025 | 41457124 | PubTator, text mining | PubMed |
| Visualizing mechanistic models by integrating site-specific molecular details into reaction networks. | Front Mol Biosci | 2025 | 41358197 | PubTator, text mining | PubMed |
| Activation of TP53 target genes in the primary response of triple-negative breast cancer cells to doxorubicin treatment. | Sci Rep | 2025 | 41345520 | PubTator, text mining | PubMed |
| [Clinical and molecular characteristics of myeloproliferative neoplasms patients with NFE2 gene mutations]. | Zhonghua Xue Ye Xue Za Zhi | 2025 | 41339048 | PubTator, text mining | PubMed |
| AMPK phosphorylates WIP1 to promote DNA repair and radioresistance in cancer cells. | Cell Death Dis | 2025 | 41315219 | PubTator, text mining | PubMed |
| Context-aware gene dependency modeling via graph attention networks for precision oncology. | J Transl Med | 2025 | 41291726 | PubTator, text mining | PubMed |
| IBI-DT: a novel approach combining individualized Bayesian inference and decision tree for identifying cancer drivers and their interactions. | Brief Bioinform | 2025 | 40975833 | PubTator, text mining | PubMed |
| Wip1 enhances genotoxic stress-induced autophagy via ULK1 dephosphorylation in Medulloblastoma cells. | Mol Biol Rep | 2025 | 40960576 | PubTator, text mining | PubMed |
| Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes. | medRxiv | 2025 | 40950448 | PubTator, text mining | PubMed |
| PPM1D is directly degraded by proteasomes in a ubiquitination-independent manner through its carboxyl-terminal region. | J Biomed Sci | 2025 | 40931354 | PubTator, text mining | PubMed |
| Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis. | Nat Genet | 2025 | 40877435 | PubTator, text mining | PubMed |
| H3F3B p.K27I-mutant diffuse midline glioma is a distinct subtype of H3K27-altered diffuse midline glioma. | Acta Neuropathol Commun | 2025 | 40849656 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8493/papers?page=4